| | | | |
CUSIP NO. 270087109 | | 13D | | Page 6 of 7 Pages |
This Amendment No. 4 (“Amendment No. 4”) to Schedule 13D amends the initial Statement on Schedule 13D filed on October 30, 2020 (as so amended, the “Schedule 13D”), relating to the common stock, par value $0.0001 per share (“Common Stock”), of Eargo, Inc., a Delaware corporation (the “Issuer”). This Amendment No. 4 reflects, among other things, the sales of shares of Common Stock by Cooperatieve Gilde Healthcare V U.A. (“Gilde Healthcare”). Capitalized terms used but not defined in this Amendment No. 4 shall have the same meanings ascribed to them in the Schedule 13D.
Item 1. Security and Issuer.
There are no changes to the Item 1 information previously filed.
Item 2. Identity and Background.
There are no changes to the Item 2 information previously filed.
Item 3. Source and Amount of Funds or Other Consideration.
There are no changes to the Item 3 information previously filed.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following:
Between October 7, 2022 and October 11, 2022, Gilde Healthcare sold an aggregate of 250,000 shares of Common Stock of the Company in open market transactions.
Item 5. Interest in Securities of the Issuer.
Item 5 is hereby amended and restated in its entirety below:
(a) According to the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on August 8, 2022, there were 39,385,438 shares of Common Stock outstanding as of August 3, 2022.
Gilde Healthcare is the record holder of an aggregate of 1,869,290 shares of Common Stock, which represents beneficial ownership of approximately 4.75% of the outstanding shares of Common Stock as of August 3, 2022.
GHCVM, as the manager of Gilde Healthcare, has the power to vote and dispose of securities held by Gilde Healthcare and may be deemed to beneficially own the securities held of record by Gilde Healthcare.
As a result, each of the Reporting Persons may beneficially own 1,869,290 shares of Common Stock, or approximately 4.75% of the outstanding Common Stock.
(b) Each Reporting Person has shared power to vote and dispose of 1,869,290 shares of Common Stock.
(c) Except as reported on Annex A, none of the Reporting Persons has effected any transactions in the Issuer’s securities within the past 60 days.
(d) Only Gilde Healthcare has the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by Gilde Healthcare.
(e) As a result of the transactions described herein, the Reporting Persons ceased to be the beneficial owner of more than 5% of the Issuer’s outstanding Common Stock. The filing of this Amendment No. 4 represents the final amendment to this Schedule 13D and constitutes an exit filing for the Reporting Persons.